BrdU) is a thymidine analogue which can be detected by monoclonal antibodies (MAb). We have developed a method for the simultaneous visualization of BrdU and a wide range of neural antigens in paraformaldehyde-fixed brain sections. Pregnant mice were injected intraperitoneally with a single pulse ofBrdU. Young adult offspring were processed for immunocytochemistry following a double immunoperoxidase sequence. BrdU was detected using diaminobenzidine (DAB) intensified with nickel ammonium sulfate and neural antigen-antaining elements were visualized with DAB alone. BrdU-positive nudei and tissue antigen-inununoreactive cells were easily differentiated. Furthermore, double-labeled cells characterized by the pres-260 SORIANO, DEL RIO DOUBLE LABELING WITh BrdU IN NEURAL TISSUE 261
Introduction

5'-Bromodeoxyuridine
(BrdU) is a thymidine (Thy) analogue which is incorporated into the DNA during S-phase ofthe cell cycle. Cell nuclei that have incorporated BrdU can be detected by monoclonal antibodies (MAb) and immunocytochemistry (5, 10, 11, 17, 21, 40) .
Therefore, the immunocytochemical visualization of BrdU appears to be a powerful alternative to [3H]-Thy autoradiography and is increasingly used in studies of cell kinetics, both in cultures and in experiments in vivo (5, 8, 10, 26, 31, 41) . BrdU immunohistochemistry is also ofinterest for pathological analysis oftumors in humans (17) (18) (19) (20) 27 ).
In the nervous system, BrdU immunohistochemistry has been proposed as a valuable tool to analyze the proliferation, time of origin, and migration ofneurons and glial cells (7, 12, 25, 28, 41, 45) . The brains were dissected out and stored in the same fixative for a futher 3 hr. After cyroprotection in PBS with 30% sucrose, 20-40-.tm sections were cut on a freezing microtome. Sections were collected in PBS and processed free-floating for the rest of the procedure.
Alternatively, they were mounted on gelatinized slides, dried for 2 hr at 37'C, and processed for immunocytochemistry the next day.
SORIANO, DEL RIO
BrdU Immunocytochemistry
BrdU was detected essentially using the procedure described previously (7) . 
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. of BrdU was similar to that of our previous study (7) . Examples illustrating the distribution of BrdU-positive nuclei in several brain regions after an E13 injection are shown in Figure 1 . In the cerebral cortex, BrdU-containing nuclei were observed in the infragranular layers ( Figures  1A and 1B) , in contrast to sections labeled with BrdU on embryonic days later than E15, where they were observed in supragranular layers ( Figure 2B ). Heavily and lightly stained nuclei, probably representing successive neuronal generations (7), were also observed ( Figure  1B) . 2B, 2D, and 2E) . Therefore, staining of neuronal perikarya, dendrites, and even of thin fibers and axonal varicosities was readily apparent. Glial cells also displayed satisfactory GFAP immunoreactivity ( Figure  3E and 3F (12, 30, 41, 43 
